Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where HealthEquity is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-10-09Current report (material event)
- SCHEDULE 13G/A2026-10-09SCHEDULE 13G/A
- 8-K2026-09-30Current report (material event)
- S-82026-08-27Employee stock plan
- 10-Q2026-08-27Quarterly report
- 8-K2026-08-27Current report (material event)
- SCHEDULE 13G/A2026-07-31SCHEDULE 13G/A
- SCHEDULE 13G/A2026-07-15SCHEDULE 13G/A
- S-82026-06-26Employee stock plan
- 8-K2026-06-26Current report (material event)
- 10-Q2026-05-28Quarterly report
- 8-K2026-05-28Current report (material event)
- ARS2026-05-13Annual report to holders
- DEFA14A2026-05-13DEFA14A
- DEF 14A2026-05-13Proxy statement
- 8-K2026-05-08Current report (material event)
- SCHEDULE 13G2026-04-30SCHEDULE 13G
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- 8-K2026-04-06Current report (material event)
- 8-K2026-03-30Current report (material event)
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 10-K2026-03-17Annual report
- 8-K2026-03-17Current report (material event)
- 8-K2026-02-17Current report (material event)
- UPLOAD2026-02-05UPLOAD
- CORRESP2026-01-29CORRESP
- UPLOAD2026-01-27UPLOAD
- 8-K2026-01-12Current report (material event)
- 10-Q2025-12-03Quarterly report
- 8-K2025-12-03Current report (material event)
- SCHEDULE 13G/A2025-11-05SCHEDULE 13G/A
- 10-Q2025-09-02Quarterly report
- 8-K2025-09-02Current report (material event)
- 8-K2025-06-27Current report (material event)
- 10-Q2025-06-03Quarterly report
- 8-K2025-06-03Current report (material event)
- ARS2025-05-13Annual report to holders
- DEFA14A2025-05-13DEFA14A
- DEF 14A2025-05-13Proxy statement
- 8-K2025-04-28Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.